Gujarat Themis Biosyn Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Gujarat Themis Biosyn Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
168.51% Gain from 52W Low
13
TTM PE Ratio
Above industry Median
48.6
Price to Book Ratio
High in industry
14.3
Dividend yield 1yr %
Below industry Median
0.2
TTM PEG Ratio
PEG TTM is much higher than 1
23.6
RSI
RSI is mid-range
41.8
MFI
MFI oversold
27.8

Gujarat Themis Biosyn Ltd shareholding Pattern

Promoter
70.9%
Foreign Institutions
1%
Mutual Funds
0.8%
Domestic Institutions
0.8%
Public
27.3%
Promoter
70.9%
Foreign Institutions
0.9%
Public
28.2%
Promoter
75%
Public
25%
Promoter
75%
Public
25%
Promoter
75%
Public
25%
Promoter
75%
Public
25%

Gujarat Themis Biosyn Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
9
Bearish Moving Averages
7
5Day EMA
392.70
10Day EMA
397.20
12Day EMA
398.10
20Day EMA
399.20
26Day EMA
398.20
50Day EMA
387.40
100Day EMA
354.00
200Day EMA
299.00
5Day SMA
393.10
10Day SMA
400.60
20Day SMA
404.10
30Day SMA
401.00
50Day SMA
391.80
100Day SMA
362.50
150Day SMA
307.80
200Day SMA
275.20
Delivery & Volume
Resistance & Support
388.63
Pivot
Resistance
First Resistance
392.27
Second Resistance
398.53
Third Resistance
402.17
Support
First Support
382.37
Second support
378.73
Third Support
372.47
Relative Strength Index
41.81
Money Flow Index
27.81
MACD
-0.08
MACD Signal
3.37
Average True Range
14.32
Average Directional Index
20.60
Rate of Change (21)
-4.62
Rate of Change (125)
102.94
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Morepen Laboratories Ltd.
2473.55
25.34
56.35
Sequent Scientific Ltd.
2652.73
71.56
155.45
Novartis India Ltd.
-
-
-
Gujarat Themis Biosyn Ltd.
-
-
-
Supriya Lifescience Ltd.
2903.01
231.05
423.5
Jeena Sikho Lifecare Ltd.
-
-
-
Innova Captab Ltd.
2836.64
444
590

Gujarat Themis Biosyn Ltd Company background

Founded in: 1981
Promoted by Kantilal Shah, Gujarat Themis Biosyn Limited was incorporated in 1981 as a joint sector company with Gujarat Industrial Investment Corporation Ltd (GIIC) and Chemosyn (P) Ltd. The Company commenced production in August 1985. It was subsequently taken over in June 1991 by Yuhan Group, South Korea and Pharmaceutical Business Group (India) Ltd. (PBG) a unique consortium of five competing drug companies Themis Medicare Ltd., Kopran Ltd., Anant Co., Cadila Health Care Ltd. (Zydus) and Lyka Labs Ltd. It is being actively managed by Themis Medicare Ltd. (JV company of Gedeon Richter Ltd, Hungary) since 2007.Initially manufacturing the antibiotic, erythromycin, GTBL obtained licences to manufacture bulk drugs like rifampicin, cephalexin, griseofulvin and their formulations in 1990. However, problems relating to purity levels, yield and imports put the company in the red and it became a BIFR case in 1990. Subsequently, it was taken over by a group consisting of Lyka Labs, Themis Chemicals, Kopran and Cadila. Also, Yuhan Corporation, South Korea, brought in technology and finance for running GTBL.During 199596 the paidup share capital increased from Rs 11.25 crores to Rs 11.60 crores after allotment of 350,000 Equity shares of Rs 10 each at a premium of Rs 20 per share to the financial institutions by way of conversion of fund interst term loan. During the year installed capacity of rifamysinS was increased to 90 mtpa and expansion of rifampicin was achieved to the maximum capacity of 120 mtpa. It also commenced operations of its new pharmaceutical division and launched a wide range of antituberculosis products and other antibiotics.The company is constantly identifying new areas for diversification and also capacity expansion of exisiting product in order to further reduction in cost of production and increase in turnover.
Read More

Gujarat Themis Biosyn Ltd FAQs

The past 1-year return of Gujarat Themis Biosyn Ltd [GUJTHEMIS] share was 168.29. The Gujarat Themis Biosyn Ltd [GUJTHEMIS] share hit a 1-year low of Rs. 147.48 and a 1-year high of Rs. 435.

The Mutual Fund Shareholding was 0.8% at the end of .

You can easily buy Gujarat Themis Biosyn Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage